I
s
E
w
q
t--p
/\
On
December
9
1988,
the
DNA committee
(RAC)
of
the
National
lnstitute
of
Health
in
the United
States
approved the
first
genetic therapy
application
in a
clinical setting. This
was
a
milestone
in
the medical history. Since then, much progress
has
been
made.
Up
to
September
1993,
the
NIH have
approved
58
types of genetic therapy that were used
to
treat
over
100
or more
patients. Most
of
these
reported favorable results.
Such
progress
exceeded expectation. More applcviations on genetic therapy
are
being studied
and
await approval before the
NlH.
ln
Europe,.countries like
the
United
Kingdom,
France
and
ltaly
are
following
the
trend.
The
governments
have also
appropriated
funds
to
support
and
test
genetic therapy in clinical
trials.
1e88+1zBeFt,-EEil*rftffi4,ffi,
(
NIH
)
TEHTE
f€DNA=E€
(
NEC
), ftETH_FIIEEI
aHHfiftETE_
R'
rld[Hff+g,l.===HllEfEfi+
"
fieE#FF*F.l='
ElENta
Ft+
r:rifl
i:EaFE,
ffi
E
1
se3+s,E'
Nl
HHt RAC
e+B#s8rF;E
tri6ffir5-F,
Eil#i=1ooffiz\,
&*.L#JtrEF,}f.
"
iElENifi)H
iEE2'JIIFf,U
'
t*H+z\'1F5Hti429l"
ElEf,
,
E&#JfrF'E
iEttriEtfirTf;
'
iEIAEFftnF.HTEiE
"
/
t
\ --
'ts
t^
,_
Etr;6HH!f,ffi
4Eq*AffiE^ft,t\'AM1+F
ahffircffiHqtr*!+Eq
'*14
HiEH'Hiti*flS
tr
r04trl€,^.
fl,*nfiE^ff-tr-H*tti=
"
2
EHlEtrHTE=]F'F
@rL.+effi.eF8hw
,?
DNA
re
+*
EE
ffr
4E
4L,
A
ffi.ft#
k!#
Eg'
JILY*iEE
ttWE
#r
e
Eq'
flffi
nER€.'{d++tE
H
rOzKE
;
:.1
r'
\.
I -(
'I
